GlassScriptPhysician profile
Rebecca Schultz
NPI 1184375925
$456.04
in general payments reported to CMS, 2019-2025
10 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $13.88 · 2024: $79.52 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.29 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $158.38 | 2022-2025 | Impella |
| Astellas Pharma US INC | $99.00 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.30 | 2024-2025 | Lifevest |
| Becton, Dickinson and Company | $31.38 | 2025 | Hemosphere |
| Edwards Lifesciences Corporation | $30.08 | 2022 | |
| Solventum Corporation | $23.51 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Chiesi USA, INC. | $21.49 | 2022 | |
| Paladin Technology Solutions | $19.49 | 2024 | |
| La Jolla Pharmaceutical Company | $16.53 | 2025 | Giapreza |
| Getinge USA Sales, LLC | $13.88 | 2023 | Vasoview Hemopro 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.